Meeting Announcements
Tackling the Next Generation of Resistance in EGFR -Mutant Lung Cancer
HER2 Transmembrane Domain Mutations: Rare New Target for Non–Small Cell Lung Cancer Therapy
Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease
Increasing Rates of No Treatment in Advanced-Stage Non–Small Cell Lung Cancer Patients: A Propensity-Matched Analysis
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib
Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases
Radiomic-Based Pathological Response Prediction from Primary Tumors and Lymph Nodes in NSCLC
Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma
Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK –Positive Human Non–Small Cell Lung Cancer
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis
A Histologic Basis for the Efficacy of SBRT to the lung
Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non–Small Cell Lung Cancer
EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients
Lower Incidence of Esophagitis in the Elderly Undergoing Definitive Radiation Therapy for Lung Cancer
Stereotactic Ablative Radiation Therapy for Lung Oligometastases: Predictive Parameters of Early Response by 18FDG-PET/CT
A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non–Small Cell Lung Cancer
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib
Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed
Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer
EGFR–Co-Mutated Advanced NSCLC and Response to EGFR Tyrosine Kinase Inhibitors
Screening for Brain Metastases in Resectable Non–Small Cell Lung Cancer
Response to Screening for Brain Metastases in Resectable Non–Small Cell Lung Cancer
Comprehensive Hybrid Capture–Based Next-Generation Sequencing Identifies a Double ALK Gene Fusion in a Patient Previously Identified to Be False-Negative by FISH
The Clinical Implications and Thoughts on Different Patterns in Resected Lung Adenocarcinoma
The Clinical Impact of Solid and Micropapillary Patterns in Resected Lung Adenocarcinoma: Author's Reply
Radical-Intent Treatment of Lung Cancer after Prior Thoracic Radiotherapy